glp-1 obesity drug news today oct 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Receptor Agonists – From

Here is what emerged: At 0.3 mg, side effects were minimal

Studies have shown that IL-17A downregulates the expression of downstream target genes in the Wnt/-catenin signalling pathway, such as AXIN2 and CCND1, in osteoblasts and osteocytes, leading to bone loss by inhibiting the activity of osteoblasts and osteocytes

I mean, why not

Risk of developing PTSD is influenced by adverse childhood experiences, younger age and socioeconomic disadvantage (Xue et al., 2015) with prevalence rates twice as high in females than in males (Perrin et al., 2014)

It's just another kind of trolling, which is probably why they're so glib about using it